West Pharmaceutical Services Target Price

See West Pharmaceutical Services's analyst price targets ($410) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$346.23

Average Target Price

$407.43

17.7% upside

7 analysts in the last 4 months

High: $447 | Low: $365

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-09-09	UBS	$415	19.9% upside
2026-07-27	Evercore ISI	$425	22.8% upside
2026-07-13	BNP Paribas	$447	29.1% upside
2026-07-09	Morgan Stanley	$365	5.4% upside
2026-07-06	Evercore ISIDaniel Markowitz	$410	18.4% upside
2026-07-02	KeyBanc	$390	12.6% upside
2026-06-09	BarclaysLuke Sergott	$400	15.5% upside
2026-04-27	Morgan Stanley	$315	9% downside
2026-04-27	Barclays	$310	10.5% downside
2026-02-13	UBSDan Leonard	$340	1.8% downside
2026-02-13	Deutsche Bank	$315	9% downside
2026-02-13	BarclaysLuke Sergott	$265	23.5% downside
2026-02-10	JefferiesDavid Windley	$295	14.8% downside
2026-02-03	Evercore ISIDaniel Markowitz	$320	7.6% downside
2025-12-01	Morgan Stanley	$285	17.7% downside
2025-10-27	Barclays	$325	6.1% downside
2025-10-24	UBSDan Leonard	$355	2.5% upside
2025-10-24	Deutsche BankJustin Bowers	$345	0.4% downside
2025-10-23	Evercore ISIDaniel Markowitz	$390	12.6% upside
2025-10-07	Evercore ISI	$350	1.1% upside
2025-10-02	Barclays	$275	20.6% downside
2025-09-15	Redburn PartnersJamie Clark	$311	10.2% downside
2025-06-24	BarclaysLuke Sergott	$245	29.2% downside
2024-11-19	JefferiesDavid Windley	$393	13.5% upside
2024-02-07	JefferiesDavid Windley	$536	54.8% upside
2022-12-14	Deutsche Bank	$250	27.8% downside
2022-11-30	UBS	$250	27.8% downside

West Pharmaceutical Services (WST) FAQ

As of the most recent data, WST shows a target price of $410. Scroll down for historical charts and peer comparison views.

If West Pharmaceutical Services moved to the average analyst target of $410, shares would be roughly 17.7% higher than $346.23. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of West Pharmaceutical Services's earnings trajectory.

Besides this target price page, Stockcircle has West Pharmaceutical Services's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $410) with ownership activity and broader fundamentals.

West Pharmaceutical Services's target price is $410; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.